Kymera Therapeutics Inc Long-term Investment Intensity
Kymera Therapeutics Inc long-term investment intensity. Kymera Therapeutics Inc (KYMR) has a Long-term Investment Intensity of 49.5% as of June 2026. Long-term investments of $813.90 Million represent 49.5% of total assets of $1.65 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of Kymera Therapeutics Inc for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Kymera Therapeutics Inc (2020–2025)
Long-term investment intensity of Kymera Therapeutics Inc from 2020 to 2025. This chart shows how Kymera Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the intensity stands at 49.5%, reflecting long-term investments of $813.90 Million against total assets of $1.65 Billion USD.
Kymera Therapeutics Inc Long-term Investment Intensity by Year (2020–2025)
Kymera Therapeutics Inc long-term investment intensity by year from 2020 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Kymera Therapeutics Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Kymera Therapeutics Inc balance sheet assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 44.2% | $771.16 Million | $1.74 Billion | ▲ +7.2 pp |
| 2024 | 37.0% | $362.16 Million | $978.03 Million | ▲ +26.4 pp |
| 2023 | 10.7% | $61.43 Million | $575.76 Million | ▼ -14.6 pp |
| 2022 | 25.3% | $152.33 Million | $603.13 Million | ▲ +4.6 pp |
| 2021 | 20.7% | $125.19 Million | $605.90 Million | ▼ -12.7 pp |
| 2020 | 33.4% | $162.53 Million | $487.18 Million | — |